Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETHEMA LPA2012 Guidelines for APL
NCT02020161Phase 4Unknown
- Sponsor
- Fundación PETHEMA
- Start
- Jun 2012
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tretinoin, idarubicin in acute promyelocytic leukemia (APL), sponsored by Fundación PETHEMA. Status: unknown.
02
Drugs
tretinoinidarubicin
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT02020161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020161.